NASDAQ:ARCT
Arcturus Therapeutics Holdings Inc. Stock News
$27.27
+0.750 (+2.83%)
At Close: May 03, 2024
Arcturus Therapeutics Holdings Inc. (ARCT) CEO Joseph Payne on Q2 2021 Results - Earnings Call Transcript
01:26am, Tuesday, 10'th Aug 2021
Arcturus Therapeutics Holdings Inc. (ARCT) CEO Joseph Payne on Q2 2021 Results - Earnings Call Transcript
Arcturus Therapeutics (ARCT) Reports Q2 Loss, Lags Revenue Estimates
06:28pm, Monday, 09'th Aug 2021
Arcturus Therapeutics (ARCT) delivered earnings and revenue surprises of -4.02% and -27.10%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Earnings Previews: AMC, New Oriental Education and 3 Cathie Wood Picks
01:23pm, Friday, 06'th Aug 2021
More than a third of earnings reports released Friday morning failed to meet consensus estimates for profits, revenues or both.
Why Arcturus Therapeutics Stock Is Soaring Today
11:21am, Tuesday, 03'rd Aug 2021
The company received a green light to advance two COVID-19 vaccine candidates into clinical testing in a second country.
ARCT Stock Price Increases Over 6% Pre-Market: Why It Happened
07:47am, Tuesday, 03'rd Aug 2021
The stock price of Arcturus Therapeutics Holdings Inc. (Nasdaq: ARCT) increased by over 6% pre-market. This is why it happened.
Earnings Preview: Arcturus Therapeutics (ARCT) Q2 Earnings Expected to Decline
04:46pm, Monday, 02'nd Aug 2021
Arcturus Therapeutics (ARCT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Arcturus Therapeutics Stock Jumps On Establishment Of COVID-19 Vaccine Plant In Vietnam
09:08am, Monday, 02'nd Aug 2021
Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) has collaborated with Vinbiocare to establish a manufacturing facility in Vietnam for its investigational COVID-19 vaccines for sale and use with
SAN DIEGO--(BUSINESS WIRE)---- $ARCT #ClinicalTrial--Arcturus Collaborates with Vingroup to Establish Manufacturing Facility in Vietnam for Arcturus' Investigational mRNA Vaccines for COVID-19
Can Last Year's Biggest Vaccine Stocks Crush the Market Again?
06:00am, Monday, 02'nd Aug 2021
These players delivered triple- and quadruple-digit gains.
Arcturus Therapeutics Holdings' (ARCT) CEO Joseph Payne on Q1 2021 Results - Earnings Call Transcript
10:44pm, Monday, 10'th May 2021
Arcturus Therapeutics Holdings' (ARCT) CEO Joseph Payne on Q1 2021 Results - Earnings Call Transcript
Arcturus Therapeutics (ARCT) Reports Q1 Loss, Lags Revenue Estimates
09:02pm, Monday, 10'th May 2021
Arcturus Therapeutics (ARCT) delivered earnings and revenue surprises of -85.34% and -27.55%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock
Arcturus Therapeutics: Q1 Earnings Insights
04:51pm, Monday, 10'th May 2021
Shares of Arcturus Therapeutics (NASDAQ:ARCT) fell in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share were down 220.90% over the past year to ($2.15),
Arcturus Therapeutics to Report First Quarter 2021 Financial Results and Provide Corporate Update on May 10, 2021
08:30am, Monday, 03'rd May 2021
SAN DIEGO--(BUSINESS WIRE)---- $ARCT #ClinicalTrial--Arcturus Therapeutics to Report First Quarter 2021 Financial Results and Provide Corporate Update on May 10, 2021
Earnings Preview: Arcturus Therapeutics (ARCT) Q1 Earnings Expected to Decline
06:03pm, Thursday, 29'th Apr 2021
Arcturus Therapeutics (ARCT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Arcturus Therapeutics Holdings Inc. (ARCT) CEO Joseph Payne on Q4 2020 Results - Earnings Call Transcript
09:43pm, Monday, 01'st Mar 2021
Arcturus Therapeutics Holdings Inc. (ARCT) CEO Joseph Payne on Q4 2020 Results - Earnings Call Transcript
